science short

Probiotics linked to liver fat reduction in rat study

By Annie Harrison-Dunn contact

- Last updated on GMT

Probiotic strains reduce fatty liver condition and has an anti-inflammatory effect in obese Zucker rats, according to research. Photo credit: Alexey Krasavin.
Probiotic strains reduce fatty liver condition and has an anti-inflammatory effect in obese Zucker rats, according to research. Photo credit: Alexey Krasavin.

Related tags: Fatty liver, Non-alcoholic fatty liver disease

Probiotic consumption for thirty days was associated with a reduction of fat accumulation in the liver of obese rats, say Spanish researchers.

The University of Granada team looked at the impact of probiotic strains Lactobacillus paracasei​, Bifidobacterium breve​ and Lactobacillus rhamnosu on ​steatosis on the accumulation of fat in the liver, the first stage of non-alcoholic fatty liver disease (NAFLD), a condition linked to obesity and diabetes.

A reduction in liver steatosis (accumulation of fat in the liver) in the strain-fed obese Zucker-Lepr rats was observed as well as “clear anti-inflammatory effects”, ​when compared to placebo-fed obese and ‘lean’ rats over a period of 30 days. The obese rats developed obesity through a mutation in the gene that codifies the receptor of satiety hormone leptine.

"The probiotic strains reduced hepatic steatosis in part by lowering serum lipopolysaccharide, and had an anti-inflammatory effect in obese Zucker rats,"​ the researchers wrote. 

The fat rats

Triacylglycerol content decreased in the liver of obese rats fed L. rhamnosus​, B. breve​, or the mixture of B. breve​ and L. paracasei​, the researchers said.

Meanwhile, the area corresponding to neutral lipids was significantly smaller in the liver of all four groups of the probiotic-fed obese rats compared to rats fed the placebo.

The obese rats exhibited significantly greater serum lipopolysaccharide (LPS) levels than Zucker-lean rats after 30 days of placebos. In contrast, all four groups of the obese rats that received lactic acid bacterial strains exhibited serum LPS concentrations similar to those of 'lean' rats.

Serum tumour necrosis factor (TNF) -α levels decreased in the obese rats that received B. breve​, L. rhamnosus​ or a mixture of the strains, whereas L. paracasei​ feeding decreased interleukin 6 - a pro-inflammatory cytokine - levels in the serum of obese rats.

This study was financed by the food firm Hero Spain, a manufacturer of infant nutrition and other food and pharma products.

 

Source: Plos One

Published online ahead of print, DOI: 10.1371/journal.pone.0098401

“Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats”

Authors: J. Plaza-Diaz, C. Gomez-Llorente, F. Abadia-Molina, M. J. Saez-Lara, L. Campaña-Martin, S. Muñoz-Quezada, F. Romero, A. Gil, L. Fontana                                                                                                                                       

Related news

Show more

Related products

show more

The CBD opportunity is waiting…are you ready?

The CBD opportunity is waiting…are you ready?

DSM Nutritional Products | 04-Oct-2021 | Infographic

CBD is set to shake up the dietary supplements industry. And with DSM as your end-to-end partner, you can be at the forefront of CBD innovation.

SLAB51®: the “oxygen-sparing” probiotic

SLAB51®: the “oxygen-sparing” probiotic

ORMENDES S.A. | 01-Oct-2021 | Product Brochure

COVID-19 patients treated with the probiotic SLAB51-Sivomixx®800 have a significantly reduced risk of intubation and mortality. SLAB51 facilitates the...

BSCU1, a probiotic that may support immunity

BSCU1, a probiotic that may support immunity

Gnosis by Lesaffre USA | 23-Sep-2021 | Technical / White Paper

LifeinU™ BSCU1 is a unique and patented probiotic strain of Bacillus subtilis with an extreme stability offered by Gnosis by Lesaffre. This specific probiotic...

Related suppliers

Follow us

Products

View more

Webinars